MindBio Therapeutics Corp. said that “MB22001, a proprietary and self-titratable form of Lysergic Acid Diethylamide (LSD) designed for safe take home microdosing” has been approved for…
The number of clinical trials using cannabis-based medicines to treat patients with symptoms from a variety of conditions, including cancer, epilepsy, and autism spectrum disorder, has…
The United States Food and Drug Administration, aka the FDA, issued the first-ever guidance for clinical studies on psychedelics, according to a news release issued Friday.…
The University of Exeter, a university in the United Kingdom, is debuting one of the first postgraduate qualifications on psychedelics in the world, the Guardian reports.…
